Effects of phenylalanine on reproductive performance and teratogenesis in mice

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5606-5616

  Oliveira, R J ^a   Pesarini, J R ^a,b   Mauro, M O ^a,b   Fronza, L S ^b   Victorelli, S G ^c   Cantero, W B ^a   Sena, M C ^a   Antoniolli, A C M B ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b Centro Univ Filadélfia   (Brazil)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Mice; Phenylalanine; Reproductive performance; Teratogenesis

Indexed keywords

CYCLOPHOSPHAMIDE; PHENYLALANINE; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DEVELOPMENT; FEMALE; FETUS; FETUS WEIGHT; GESTATIONAL AGE; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PONDERAL DEVELOPMENT; PROTECTION; REPRODUCTIVE SUCCESS; WEIGHT REDUCTION; ANIMAL; DRUG EFFECTS; ORGAN SIZE; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTION; TERATOGENESIS; UTERUS;

ANIMALS; CYCLOPHOSPHAMIDE; FEMALE; MALE; MICE; ORGAN SIZE; PHENYLALANINE; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTION; TERATOGENESIS; TERATOGENS; UTERUS;

EID: 84901599044     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.25.16     Document Type: Article

References (34)

1. Abadie V (1995). Le Nouveau-né de Mère Phénylcétonurique. In: Progrès en Néonatologie, Journées Nationales de Néonatologie (Relier JP, ed.). Karger Publisher, Basel, 117-126.
2. Barreiros ALBS, David JM and David JP (2006). Estresse oxidativo: relação entre geração de espécies reativas e defesa do orgnismo. Quím. Nova 29: 113-123.
3. Barrow MV and Taylor WJ (1969). A rapid method for detecting malformations in rat fetuses. J. Morphol. 127: 291-305.
4. Borges VC (2001). Alimentos Funcionais: Prebióticos, Probióticos, Fitoquímicos e Simbióticos. In: Nutrição Oral, Enteral e Parenteral na Prática Clínica (Waitzberg DL, ed.). Editora Atheneu, São Paulo, 1495-1509.
5. Calderon IPM (1988). Modelo Experimental em Ratas Para Estudo do Binômio Diabete e Gravidez. Faculdade de Medicina, Universidade Estadual de Paulista, Botucatu.
6. Campistol J, Lambruschini N, Vilaseca MA and Canbra FJ (2001). Hiperfenilalaninemia. In: Diagnostico y Tratamiento de las Enfermedades Metabólicas Hereditárias (Sanjurjo P, Baldellou A and Ergon SA, eds.). Madrid, 195-206.
7. Cetin I, Corbetta C, Sereni LP, Marconi AM, et al. (1990). Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. Am. J. Obstet. Gynecol. 162: 253-261.
8. Degáspari CH and Waszczynskyj N (2004). Propriedades antioxidantes de compostos fenólicos. Visão Acadêmica 5: 33-40.
9. Del-Vechio G, Corrêa AD, Abreu CMP and Santos CD (2005). Efeito do tratamento térmico em sementes de abóbora (Curcubita spp.) sobre os níveis de fatores antinutricionais e/ou tóxicos. Ciênc. Agrotec. 29: 369-376.
10. Ferrari CKB and Torres EAFS (2002). New dietetic compounds with anticarcinogenic properties. Rev. Bras. Canc. 48: 375-382.
11. Figueiró-Filho EA, Lopes AHA, Senefonte FRA and Souza-Júnior VG (2004). Fenilcetonúria materna: relato de caso. Rev. Bras. Ginecol. Obstet. 26: 813-817.
12. Haseman JK and Hogan MD (1975). Selection of the experimental unit in teratology studies. Teratology 12: 165-171.
13. Manson JM and Kang YJ (1994). Test Methods for Assessing Female Reproductive and Developmental Toxicology. In: Principles and Methods of Toxicology (Hayves AW, ed.). Raven Press, New York.
14. Manson JM, Zenick H and Costlow RD (1982). Teratology Test Methods for Laboratory Animals. In: Principles and Methods of Toxicology (Hayves AW, ed.). Raven Press, New York, 141-184.
15. Mauro MO, Pesarini JR, Ishii PL and Silva AF (2010). Chemopreventive activity of phenylalanine against damage mutagenic prompted by the acute administration of cyclophosphamide in pregnant and non-pregnant mice using the micronucleus test. Rev. Bras. Farmacogn. 20: 334-339.
16. Mauro MO, Monreal MT, Silva MT, Pesarini JR, et al. (2013). Evaluation of the antimutagenic and anticarcinogenic effects of inulin in vivo. Genet. Mol. Res. 12: 2281-2293.
17. Mcgahon AJ, Martin SJ, Bissonnette RP and Mahboudi A (1995). The end of the (cell) line: Methods for the study of apoptosis in vitro. In: Methods in cell Biology (Schurartz LM and Osbourne BA, eds.). Academic Press, Massachusetts, 153-184.
18. Mirkes PE (1985). Cyclophosphamide teratogenesis: a review. Teratog. Carcinog. Mutagen. 5: 75-88.
19. Naves LP, Corrêa AD, Santos CD and Abreu CMP (2010). Componentes antinutricionais e digestibilidade proteica em sementes de abóbora (Cucurbita maxima) submetidas a diferentes processamentos. Ciênc. Tecnol. Aliment. 30: 180-184.
20. O'Loughlin IB, Murray BA, Brodkorb A, FitzGerald RJ, et al. (2013). Whey protein isolate polydispersity affects enzymatic hydrolysis outcomes. Food Chem. 141: 2334-2342.
21. Oliveira RJ, Ribeiro LR, da Silva AF, Matuo R, et al. (2006). Evaluation of antimutagenic activity and mechanisms of action of beta-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test. Toxicol. In Vitro 20: 1225-1233.
22. Oliveira RJ, Matuo R, da Silva AF, Matiazi HJ, et al. (2007). Protective effect of beta-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO cells. Toxicol. In Vitro 21: 41-52.
23. Oliveira RJ, Baise E, Mauro MO, Pesarini JR, et al. (2009). Evaluation of chemopreventive activity of glutamine by the comet and the micronucleus assay in mice's peripheral blood. Environ. Toxicol. Pharmacol. 28: 120-124.
24. Oliveira RJ, Salles MJ, da Silva AF, Kanno TY, et al. (2013). In vivo evaluation of the antimutagenic and antigenotoxic effects of beta-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses. Genet. Mol. Biol. 36: 413-424.
25. Pesarini JR, Zaninetti PT, Mauro MO, Carreira CM, et al. (2013). Antimutagenic and anticarcinogenic effects of wheat bran in vivo. Genet. Mol. Res. 12: 1646-1659.
26. Poersch A, dos Santos FV, Maciel MA, de Camara JK, et al. (2007). Protective effect of DCTN (trans-dehydrocrotonin) against induction of micronuclei and apoptosis by different mutagenic agents in vitro. Mutat. Res. 629: 14-23.
27. Silva MR and Silva MAAP (2000). Fatores antinutricionais: inibidores de proteases e lectinas. Rev. Nutrição 13: 3-9.
28. Sperber EF, Salomon LM and Dow-Edwards D (1995). Prenatal exposure to aspartame and seizure susceptibility. J. Epilepsy 8: 51-56.
29. Spiers PA, Sabounjian L, Reiner A, Myers DK, et al. (1998). Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects. Am. J. Clin. Nutr. 68: 531-537.
30. Stahlmann R, Bluth U and Neubert D (1985). Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures. Arch. Toxicol. 57: 163-167.
31. Taylor P (1986). Pratical Teratology. Academic Press, New York.
32. Waters MD, Brady AL, Stack HF and Brockman HE (1990). Antimutagenicity profiles for some model compounds. Mutat. Res. 238: 57-85.
33. Whitaker J (2000). The Lowdown on Aspartame. Available at [http://www.dorway.com/jwnoasp.html]. Accessed August 25, 2013.
34. Wilson JG (1965). Methods for Administeringagents and Detecting Malformations in Experimental Animals. In: Teratology: Principles and Techniques (Wilson JG and Warkany J, eds.). The University of Chicago Press, Chicago, 262-277